Facebook
Twitter
Telegram
Report an ErrorAchieve Life Sciences Financial Statements 2011-2024 | ACHV
Annual Financial Statements Achieve Life Sciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
90.2 M | 48.2 M | 63.2 M | 22 M | 4.54 M | 5.12 M | 7.62 M | 16.2 M | 17.3 M | 36.4 M | 161 M | 180 M | 135 M |
Shares |
19.8 M | 10.6 M | 8.12 M | 2.72 M | 412 K | 176 K | 24 K | 13.6 K | 11.9 K | 8.23 K | 6.67 K | 6.15 K | 4.42 K |
Historical Prices |
4.55 | 4.55 | 7.78 | 8.1 | 10.6 | 24.2 | 268 | 1.1 K | 2.66 K | 5.04 K | 18.3 K | 28.9 K | 25.8 K |
Net Income |
-29.8 M | -42.4 M | -33.2 M | -14.7 M | -16.4 M | -12.7 M | -10.6 M | -20.1 M | -16.8 M | -26.2 M | -31.8 M | -21.1 M | -14.7 M |
Revenue |
- | - | - | - | - | - | - | 5.06 M | 18.2 M | 27.1 M | 29.9 M | 20.1 M | 5.5 M |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | 18.2 M | 27.1 M | 29.9 M | 20.1 M | 5.5 M |
Operating Income |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
2.85 M | 1.79 M | -75 K | -49 K | -37 K | -45 K | -35 K | -24 K | -64 K | -19 K | 120 K | 138 K | 6 K |
EBITDA |
228 K | 236 K | 250 K | 255 K | -16.3 M | -12.5 M | 838 K | -18.5 M | -18.5 M | -29.5 M | -35.1 M | -27.5 M | -22.2 M |
Operating Expenses |
- | - | - | - | 16.5 M | 12.8 M | 6.63 M | 23.7 M | 36.9 M | 56.8 M | 65.2 M | 47.7 M | 27.8 M |
General and Administrative Expenses |
11.4 M | 10.7 M | 9.13 M | 7.87 M | 6.85 M | 6.94 M | 3.53 M | 8.93 M | 11.8 M | 10.6 M | 9.89 M | 7.79 M | - |
All numbers in USD currency
Quarterly Income Statement Achieve Life Sciences
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
25 M | 21.2 M | 21.1 M | 19 M | 17.9 M | 17.9 M | 9.69 M | 9.65 M | 9.46 M | 9.45 M | 9.45 M | 7.39 M | 6.13 M | 6.11 M | 3.29 M | 1.74 M | 1.55 M | 1.47 M | 405 K | 359 K | 6.72 M | 6.72 M | 4.53 M | 1.53 M | 1.24 M | 1.19 M | 723 K | 2.12 K | 21.2 K | 21.2 K | 21.2 K | 29.9 M | 29.8 M | 29.8 M | 28.5 M | 23.5 M | 22.7 M | 22.6 M | 21.1 M | 15 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 14.6 M | 14.7 M | 14.7 M | 9.75 M | 9.74 M | 9.72 M | 9.75 M |
Net Income |
-6.49 M | - | -7.11 M | -8.24 M | -8.99 M | - | -13.1 M | -10.5 M | -7.57 M | -7.15 M | -6.69 M | -11.3 M | -8 M | -4.72 M | -3.76 M | -2.92 M | -3.32 M | -3.19 M | -3.67 M | -3.62 M | -5.9 M | -3.64 M | -3.24 M | -2.79 M | -3.02 M | -3.74 M | -6.47 M | -169 K | -205 K | -486 K | -268 K | -238 K | -242 K | -1.72 M | -4.55 M | -6.01 M | -4.52 M | -5.68 M | -4.91 M | -7.02 M | -8.64 M | -6.68 M | -10.1 M | -8.42 M | -6.7 M | -4.1 M | -5.92 M | -4.22 M | -6.86 M | -9.57 M | 4.47 M | -6.53 M | -3.04 M |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.29 M | 5.94 M | -5.5 M | - | 4.1 M | 4.99 M | -5.22 M |
Interest Expense |
813 K | - | 781 K | 712 K | 573 K | - | 481 K | 404 K | 357 K | - | -1 K | -12 K | -23 K | - | -12 K | -7 K | -5 K | - | 4 K | -3 K | -26 K | - | -7 K | -9 K | -18 K | - | -7 K | -11 K | -8 K | - | -7 K | -35 K | 10 K | - | -14 K | -7 K | -39 K | - | -11 K | -4 K | 2 K | - | -11 K | 36 K | 96 K | - | -24 K | -6 K | 23 K | - | -62 K | 87 K | -4 K |
EBITDA |
- | - | - | - | - | - | 100 K | 100 K | 60 K | - | 188 K | 127 K | 64 K | - | 191 K | 126 K | 61 K | - | 192 K | 130 K | 65 K | - | 220 K | 154 K | 86 K | - | 191 K | 111 K | 56 K | - | 166 K | 103 K | 56 K | - | 178 K | 116 K | 46 K | - | 165 K | 110 K | 55 K | - | 162 K | 100 K | 44 K | - | 8.36 M | 5.99 M | -5.48 M | - | 4.15 M | 5.03 M | -5.21 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7.37 M | - | 11.4 M | - | 6.37 M | - | 12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
3.18 M | - | 2.99 M | 3.13 M | 3.04 M | - | 2.77 M | 2.87 M | 2.84 M | 2.61 M | 2.1 M | 2.08 M | 2.34 M | 2.37 M | 1.86 M | 1.82 M | 1.82 M | 1.45 M | 1.89 M | 1.63 M | 1.88 M | 1.63 M | 1.75 M | 1.75 M | 1.81 M | 1.63 M | 1.55 M | 96 K | 260 K | 529 K | 329 K | 281 K | 289 K | 2.92 M | 3.12 M | 3.07 M | 2.7 M | 2.73 M | 2.46 M | 2.68 M | 2.76 M | 2.45 M | 2.47 M | 2.47 M | 2.5 M | 2.04 M | 1.96 M | 2.05 M | 1.74 M | 1.73 M | 1.46 M | 1.47 M | 1.57 M |
All numbers in USD currency